Reetu Mukherji, MD (@reetumukherjimd) 's Twitter Profile
Reetu Mukherji, MD

@reetumukherjimd

GI Medical Oncologist, Assistant Professor, Medstar Georgetown University Hospital

ID: 1406974538123038724

calendar_today21-06-2021 13:57:37

94 Tweet

247 Takipçi

194 Takip Edilen

Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

BostonGene Evaluates Novel Therapies and Immune System Profiling as a Marker of Response in Patients with Gastrointestinal Cancers. “We need new approaches for improving outcomes for patients with gastrointestinal cancers,” said principal investigator John Marshall of

Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

“Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal​ cancers with microscopic residual disease.” Research by Reetu Mukherji, MD, Hongkun Wang, Ruth He, MD, PhD, Marcus S. Noel, Benjamin Weinberg, MD, FACP, Louis Weiner and

“Evaluating  novel therapies and circulating tumor DNA (ctDNA) as a marker of response in  curatively treated gastrointestinal​ cancers with microscopic residual disease.”

Research by <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a>, Hongkun Wang, <a href="/RuthHe12/">Ruth He, MD, PhD</a>, <a href="/mnoel3232/">Marcus S. Noel</a>, <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a>, Louis Weiner and
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

Join us to review exciting research from the ASCO #GI25 meeting. John Marshall, Benjamin Weinberg, MD, FACP, Marcus S. Noel, Reetu Mukherji, MD will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers. Register today: bit.ly/3yFhuvr

Join us to review exciting research from the <a href="/ASCO/">ASCO</a> #GI25 meeting. <a href="/marshalj23/">John Marshall</a>, <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a>, <a href="/mnoel3232/">Marcus S. Noel</a>, <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a> will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers. Register today: bit.ly/3yFhuvr
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

“Evaluation of EpiSwitch in predicting immunotherapy response​ in hepatocellular carcinoma and gastrointestinal tumors.” Research by Mahmoud Ouf, MD, Hongkun Wang, Reetu Mukherji, MD, John MarshallRuth He, MD, PhD, and others Georgetown Lombardi. #GI25

“Evaluation of EpiSwitch in predicting immunotherapy response​ in hepatocellular carcinoma and gastrointestinal tumors.”

Research by <a href="/MahmoudOuf94/">Mahmoud Ouf, MD</a>, Hongkun Wang, <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a>, <a href="/marshalj23/">John Marshall</a>, <a href="/RuthHe12/">Ruth He, MD, PhD</a>, and others <a href="/LombardiCancer/">Georgetown Lombardi</a>. #GI25
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

“Real-world microscopic residual disease (MRD) monitoring​ with circulating tumor DNA (ctDNA) in pancreatic​ adenocarcinoma (PDAC).” Peter Li, Harrison Winters, Xue Geng, Hongkun Wang, Alan Schumann, Marcus S. Noel, Ruth He, MD, PhD, Benjamin Weinberg, MD, FACP, John Marshall, Anteneh Tesfaye,

“Real-world  microscopic residual disease (MRD) monitoring​ with circulating tumor DNA (ctDNA) in pancreatic​ adenocarcinoma (PDAC).”

Peter  Li, Harrison Winters, Xue Geng, Hongkun Wang, Alan Schumann, <a href="/mnoel3232/">Marcus S. Noel</a>, <a href="/RuthHe12/">Ruth He, MD, PhD</a>, <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a>, <a href="/marshalj23/">John Marshall</a>, Anteneh Tesfaye,
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

“Colorectal cancer care disparities in an urban ​​diverse population: A tale of two hospitals in the nation’s capital.”     New research by John Marshall, Anteneh Tesfaye, Connor Shimberg, Chelsea Perelgut, Jialing Zhu and Chiranjeev Dash at ASCO #GI25. Georgetown Lombardi MedStar Georgetown

“Colorectal cancer care disparities in an urban ​​diverse population: A tale of two hospitals in the nation’s capital.”
   
New research by <a href="/marshalj23/">John Marshall</a>, Anteneh Tesfaye, Connor Shimberg, Chelsea Perelgut, Jialing Zhu and Chiranjeev Dash at <a href="/ASCO/">ASCO</a> #GI25. <a href="/LombardiCancer/">Georgetown Lombardi</a> <a href="/MedStarGUH/">MedStar Georgetown</a>
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

Today is Dress in Blue Day! The Clinical Research Management Office and Ruesch Center faculty at Georgetown Lombardi and MedStar Georgetown wear blue to raise awareness of colorectal cancer and support the CRC community. #ColorectalCancerAwarenessMonth #DressInBlueDay

Today is Dress in Blue Day! The Clinical Research Management Office and Ruesch Center faculty at <a href="/LombardiCancer/">Georgetown Lombardi</a> and <a href="/MedStarGUH/">MedStar Georgetown</a> wear blue to raise awareness of colorectal cancer and support the CRC community. #ColorectalCancerAwarenessMonth #DressInBlueDay
Michael Serzan, MD (@mikeserzanmd) 's Twitter Profile Photo

⭐️ Navigating #ASCO25 Tips to Master Your Meetint Experience ⭐️ 🤩 Proud of Jennifer A. Marks, MD my former co-fellow MedStar Georgetown and current colleague Dana-Farber mentoring the next generation of medical oncologists with invaluable pearls!

⭐️ Navigating #ASCO25 Tips to Master Your Meetint Experience ⭐️ 

🤩 Proud of <a href="/jennifermarksmd/">Jennifer A. Marks, MD</a> my former co-fellow <a href="/MedStarGUH/">MedStar Georgetown</a> and current colleague <a href="/DanaFarber/">Dana-Farber</a> mentoring the next generation of medical oncologists with invaluable pearls!
Reetu Mukherji, MD (@reetumukherjimd) 's Twitter Profile Photo

Excited to share this collaborative effort as a poster at #ASCO2025. WES in >5800 GEC shows distinct molecular profiles across anatomical locations in one of the largest cohorts to date. Natera Sam Klempner Dr. Cathy Eng Adham Jurdi #DrMichaelGibson

Excited to share this collaborative effort as a poster at #ASCO2025. WES in &gt;5800 GEC shows distinct molecular profiles across anatomical locations in one of the largest cohorts to date. <a href="/NateraGenetics/">Natera</a> <a href="/KlempnerSam/">Sam Klempner</a> <a href="/CathyEngMD/">Dr. Cathy Eng</a> <a href="/OncoJurdi/">Adham Jurdi</a> #DrMichaelGibson
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

“Exome analysis of over 5000 esophagogastric cancers.” Research by Reetu Mukherji, MD, Vasily N, Aushev, Samuel Rivero-Hinojosa, Avinash Ramu, Alyssa Antonopoulos, Richard Green, Adham A, Jurdi, Michael K, Gibson, Dr. Cathy Eng and Samuel J, Klempner presented at ASCO25.

“Exome analysis of over 5000 esophagogastric cancers.” Research by <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a>, Vasily N,  Aushev, Samuel Rivero-Hinojosa, Avinash Ramu, Alyssa Antonopoulos, Richard Green, Adham A,  Jurdi, Michael K,  Gibson, <a href="/CathyEngMD/">Dr. Cathy Eng</a> and Samuel J,  Klempner presented at ASCO25.
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

Join us to review exciting research from the #ASCO25 Annual Meeting. John Marshall, Benjamin Weinberg, MD, FACP, Marcus S. Noel, and Reetu Mukherji, MD will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today:

Join us to review exciting research from the #ASCO25 Annual Meeting. <a href="/marshalj23/">John Marshall</a>, <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a>, <a href="/mnoel3232/">Marcus S. Noel</a>, and <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a> will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today:
Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

Join us to review research from the #ASCO25 Annual Meeting. John Marshall, Benjamin Weinberg, MD, FACP, Marcus S. Noel, and Reetu Mukherji, MD will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers via Zoom this Friday, June 27th. Register today:

Join us to review research from the #ASCO25 Annual Meeting. <a href="/marshalj23/">John Marshall</a>, <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a>, <a href="/mnoel3232/">Marcus S. Noel</a>, and <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a> will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers via Zoom this Friday, June 27th. Register today:
Ruth He, MD, PhD (@ruthhe12) 's Twitter Profile Photo

Fresh off the press! Benjamin Weinberg, MD, FACP Reetu Mukherji, MD Marcus S. Noel John Marshall Ruth He, MD, PhD , Thanks for your contribution to this project. Special thanks to Dr.Narayanan Sadagopan, our graduating fellow. nam02.safelinks.protection.outlook.com/?url=https%3A%….

Fresh off the press! <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a> <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a> <a href="/mnoel3232/">Marcus S. Noel</a> <a href="/marshalj23/">John Marshall</a> <a href="/RuthHe12/">Ruth He, MD, PhD</a> ,  Thanks for your contribution to this project. Special thanks to  Dr.Narayanan Sadagopan, our graduating fellow.  nam02.safelinks.protection.outlook.com/?url=https%3A%….
DAVA Oncology (@davaonc) 's Twitter Profile Photo

Dr. Reetu Mukherji (Reetu Mukherji, MD) presented MATTERHORN data: Durvalumab + FLOT in resectable gastric/GEJ adenocarcinoma demonstrated improved EFS and pCR with manageable safety. #DAVAGI

Dr. Reetu Mukherji (<a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a>) presented MATTERHORN data: Durvalumab + FLOT in resectable gastric/GEJ adenocarcinoma demonstrated improved EFS and pCR with manageable safety. #DAVAGI
DAVA Oncology (@davaonc) 's Twitter Profile Photo

Dr. Reetu Mukherji, MD shares WES of 5,872 gastroesophageal cancers: TP53 dominant in EC, ARID1A/CDH1 enriched in GC. Large real-world dataset highlights distinct mutational landscapes by site, guiding precision strategies in EGC #DAVAGI

Dr. <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a> shares WES of 5,872 gastroesophageal cancers: TP53 dominant in EC, ARID1A/CDH1 enriched in GC. Large real-world dataset highlights distinct mutational landscapes by site, guiding precision strategies in EGC #DAVAGI